160 related articles for article (PubMed ID: 9234374)
1. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
Mahlberg K; Uusitalo RJ; Oksala O
Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
[TBL] [Abstract][Full Text] [Related]
3. Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
Rehany U; Waisman M
Cornea; 1994 Sep; 13(5):447-53. PubMed ID: 7995070
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
[TBL] [Abstract][Full Text] [Related]
5. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
7. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine-containing collagen shields suppress corneal allograft rejection.
Chen YF; Gebhardt BM; Reidy JJ; Kaufman HE
Am J Ophthalmol; 1990 Feb; 109(2):132-7. PubMed ID: 2301524
[TBL] [Abstract][Full Text] [Related]
11. Mixed lymphocyte culture responses in rabbits undergoing corneal grafting and topical cyclosporine treatment.
Maske R; Hill JC; Horak S
Cornea; 1994 Jul; 13(4):324-30. PubMed ID: 7924332
[TBL] [Abstract][Full Text] [Related]
12. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields.
Mahlberg K; Uusitalo RJ; Gebhardt B; Kaufman HE
Graefes Arch Clin Exp Ophthalmol; 1991; 229(1):69-74. PubMed ID: 2004727
[TBL] [Abstract][Full Text] [Related]
14. The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model.
Bouchard CS; Kappil JC; Duffner L
Curr Eye Res; 1995 May; 14(5):421-4. PubMed ID: 7648869
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
16. Topical cyclosporine in pediatric keratoplasty.
Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
[TBL] [Abstract][Full Text] [Related]
17. Protection of corneal allografts by CTLA4-Ig.
Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
[TBL] [Abstract][Full Text] [Related]
18. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.
Hill JC
Ophthalmology; 1994 Jan; 101(1):128-33. PubMed ID: 8302545
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer.
Xie L; Shi W; Wang Z; Bei J; Wang S
Cornea; 2001 Oct; 20(7):748-52. PubMed ID: 11588429
[TBL] [Abstract][Full Text] [Related]
20. Topical FK-506 prevents experimental corneal allograft rejection.
Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
